Sandrine Mansard

2.4k total citations · 1 hit paper
37 papers, 799 citations indexed

About

Sandrine Mansard is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Sandrine Mansard has authored 37 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Sandrine Mansard's work include Melanoma and MAPK Pathways (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). Sandrine Mansard is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Cutaneous Melanoma Detection and Management (7 papers). Sandrine Mansard collaborates with scholars based in France, United States and Canada. Sandrine Mansard's co-authors include Marie‐Françoise Avril, Florent Grange, E. Maubec, M. D’Incan, B. Crickx, A. Dompmartin, Agnès Certain, V. Buffard, France Mentré and Isabelle Scheer-Senyarich and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Sandrine Mansard

36 papers receiving 784 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

2011 334 citations E. Maubec, Peter Petrow et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandrine Mansard France	12	499	346	231	180	130	37	799
João Pedreira Duprat Neto Brazil	16	713 1.4×	226 0.7×	112 0.5×	379 2.1×	126 1.0×	78	1.0k
Courtney W. Hudgens United States	16	544 1.1×	132 0.4×	94 0.4×	215 1.2×	269 2.1×	30	877
Hermann Kneitz Germany	12	271 0.5×	114 0.3×	137 0.6×	102 0.6×	175 1.3×	47	604
Ugo Marone Italy	17	441 0.9×	209 0.6×	126 0.5×	90 0.5×	111 0.9×	47	743
Hans Starz Germany	18	980 2.0×	553 1.6×	263 1.1×	195 1.1×	154 1.2×	37	1.2k
Suroosh S. Marzban United States	19	921 1.8×	233 0.7×	131 0.6×	235 1.3×	229 1.8×	25	1.1k
Tatsuya Takenouchi Japan	17	767 1.5×	326 0.9×	355 1.5×	369 2.0×	248 1.9×	70	1.1k
Boel Ragnarsson-Olding Sweden	20	1.1k 2.2×	317 0.9×	155 0.7×	405 2.3×	326 2.5×	30	1.4k
Giuseppe Macripò Italy	16	518 1.0×	178 0.5×	124 0.5×	158 0.9×	69 0.5×	29	593
Joanna Mangana Switzerland	20	710 1.4×	153 0.4×	110 0.5×	441 2.5×	292 2.2×	82	1.2k

Countries citing papers authored by Sandrine Mansard

Since Specialization

Citations

This map shows the geographic impact of Sandrine Mansard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Mansard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Mansard more than expected).

Fields of papers citing papers by Sandrine Mansard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Mansard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Mansard. The network helps show where Sandrine Mansard may publish in the future.

Co-authorship network of co-authors of Sandrine Mansard

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Mansard. A scholar is included among the top collaborators of Sandrine Mansard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Mansard. Sandrine Mansard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leroy, Karen, Clarisse Audigier-Valette, Jérôme Alexandre, et al.. (2023). Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study). PLoS ONE. 18(9). e0291495–e0291495. 3 indexed citations

Rouanet, Jacques, Constance Hordonneau, Bruno Pereira, et al.. (2022). Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification. International Journal of Computer Assisted Radiology and Surgery. 17(10). 1867–1877. 6 indexed citations

Dutriaux, Caroline, Caroline Robert, Jean‐Jacques Grob, et al.. (2022). An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases. European Journal of Cancer. 175. 254–262. 8 indexed citations

Saïag, Philippe, Caroline Robert, Jean‐Jacques Grob, et al.. (2021). Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib. European Journal of Cancer. 154. 57–65. 10 indexed citations

Beylot‐Barry, M., Sandrine Mansard, Jean‐Philippe Arnault, et al.. (2021). Vismodegib efficacy in unresectable trichoblastic carcinoma: A multicenter study of 16 cases. Journal of the American Academy of Dermatology. 86(6). 1365–1366. 5 indexed citations

Rouanet, Jacques, Anà Hennino, Philippe Auzeloux, et al.. (2020). Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer Immunology Immunotherapy. 69(10). 2075–2088. 28 indexed citations

Lesage, C., Christine Longvert, S. Prey, et al.. (2019). Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey. Journal of Immunotherapy. 42(5). 175–179. 57 indexed citations

Butler, Marcus O., Caroline Robert, Sylvie Négrier, et al.. (2019). ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy. Annals of Oncology. 30. v560–v561. 2 indexed citations

Saïag, Philippe, Caroline Robert, Jean‐Jacques Grob, et al.. (2018). An open-label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib for patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma. Annals of Oncology. 29. viii449–viii450. 1 indexed citations

10.

Dang, N. Pham, et al.. (2016). Eight Years' Experience of Sentinel Lymph Node Biopsy in Melanoma Using Lymphoscintigraphy and Gamma Probe Detection After Radiocolloid Mapping. Dermatologic Surgery. 43(2). 287–292. 5 indexed citations

11.

Brunot, Angélique, G. Jeudy, B. Guillot, et al.. (2016). Anti-PD-1 tolerance after severe toxicity with ipilimumab therapy in metastatic melanoma patients.. Journal of Clinical Oncology. 34(15_suppl). 9551–9551. 4 indexed citations

12.

Jouary, Thomas, Stéphane Dalle, B. Guillot, et al.. (2014). Sentinel Node Status and Immunosuppression: Recurrence Factors in Localized Merkel Cell Carcinoma. Acta Dermato Venereologica. 95(7). 0–0. 22 indexed citations

13.

Maubec, E., Peter Petrow, Isabelle Scheer-Senyarich, et al.. (2011). Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin. Journal of Clinical Oncology. 29(25). 3419–3426. 334 indexed citations breakdown →

14.

Khosrotehrani, Kiarash, Sáu Nguyễn Hữu, Aurélie Prignon, et al.. (2011). Pregnancy Promotes Melanoma Metastasis through Enhanced Lymphangiogenesis. American Journal Of Pathology. 178(4). 1870–1880. 26 indexed citations

15.

Franck, F., Juliette Joubert‐Zakeyh, Isabelle Barthélémy, et al.. (2007). Absence de valeur prédictive des signes de régression histologique sur l’envahissement du ganglion sentinelle. Annales de Dermatologie et de Vénéréologie. 134(6-7). 521–525. 6 indexed citations

16.

Mansard, Sandrine, Janine Papon, Marie‐France Moreau, et al.. (2005). Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation. Nuclear Medicine and Biology. 32(5). 451–458. 20 indexed citations

17.

Kolb, F., Alan Spatz, B Court, et al.. (2004). Mélanomes du pénis : 6 cas. Annales de Dermatologie et de Vénéréologie. 131(6-7). 541–544. 8 indexed citations

18.

Amarger, S., et al.. (2004). Generalized pustular psoriasis complicated by acute respiratory distress syndrome. British Journal of Dermatology. 150(2). 353–356. 22 indexed citations

19.

Hesling, Cédric, M. D’Incan, Sandrine Mansard, et al.. (2004). In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. British Journal of Dermatology. 150(4). 761–767. 66 indexed citations

20.

D’Incan, M., J. Gabrillargues, Sandrine Mansard, et al.. (2002). [Radiation-induced temporary hair loss after endovascular embolization of the cerebral arteries: six cases].. PubMed. 129(5 Pt 1). 703–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact